A Virtual Reality View - Biologic Agents for a Personalized Approach to Psoriasis: Improving PASI Response and Quality of Life

Released On
March 1, 2019

Expires On
March 1, 2020

Media Type
Internet

Completion Time
60 minutes

Specialty
Dermatology

Topic(s)
Psoriasis

Scroll to the Bottom of this Information to Begin this Course

Jointly provided by Med Learning Group and Ultimate Medical Academy/CCM.

 

Supported by an educational grant from Lilly.

 

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)
  • Nurses — 1.0 contact hour(s).

All other healthcare professionals completing this course will be issued a statement of participation.

Target Audience

This activity is intended for medical dermatologists, nurses, and other healthcare professionals involved in the management of patients with psoriasis.

Program Overview

This case-based enduring activity will cover the long-term treatment and management of patients with psoriasis.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe the rationale for higher PASI goals in patients with moderate-to-severe psoriasis taking biologics
  • Review the pathophysiologic similarities between psoriasis and cardiovascular disease to better manage the psoriasis patient
  • Discuss patient-focused therapeutic goals and the role of biologics in pursuing these targets

Faculty

Joel Gelfand, MD, MSCE

Professor of Dermatology and Epidemiology
Vice Chair for Clinical Research
Medical Director, Clinical Studies Unit
Director, Psoriasis and Phototherapy Treatment Center
Perelman School of Medicine
University of Pennsylvania
Philadelphia, PA

Accreditation Statement

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This CME activity was planned and produced in accordance with the ACCME Essentials.

Credit Designation

Med Learning Group designates this enduring activity for a maximum of 1.0 AMA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Purpose: This program would be beneficial for nurses involved in the long-term treatment and management of patients with psoriasis.

Accreditation Statement

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Credit Designation

Awarded 1.0 contact hour(s) of continuing nursing education for RNs and APNs.

Disclosures of Conflicts of Interest

In accordance with the Accreditation Council for Continuing Medical Education (ACCME)Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

Joel M. Gelfand, MD

  • Consultant: BMS, Boehringer Ingelheim, Janssen Biologics, Novartis Corp, Regeneron, UCB (DSMB), Sanofi and Pfizer Inc.
  • Received honoraria and research grants (to the Trustees of the University of Pennsylvania): Abbvie, Janssen, Novartis Corp, Celgene, Ortho Dermatologics, and Pfizer Inc.
  • Received payment for CME work related to psoriasis that was supported indirectly by Lilly and Novartis.

CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.

CNE Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.

The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

Matthew Frese, General Manager of Med Learning Group has nothing to disclose.

Christina Gallo, SVP, Educational Development for Med Learning Group has nothing to disclose.

Chris Drury, Medical and Scientific Services for Med Learning Group has nothing to disclose.

Melissa Johnson, Sr. Program Manager for Med Learning Group, has nothing to disclose.

Lauren Welch, MA, VP of Accreditation and Outcomes for Med Learning Group has nothing to disclose.

Disclosure of Unlabeled Use

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During the course of this lecture, Dr. Gelfand may mention the use of medications for both FDA-approved and non-approved indications

Instructions for Participation and Credit

There are no fees for participating and receiving CME/CNE credit for this enduring activity. To receive CME/CNE credit participants must:

  1. Read the CME/CNE information and faculty disclosures.
  2. Participate in the enduring activity.
  3. Submit the evaluation form to the Med Learning Group.

You will receive your certificate for download immediately, you will also get an email reminder.

For CME questions, please contact: Med Learning Group at info@medlearninggroup.com

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: http://www.medlearninggroup.com/privacy-policy/

Hardware and Software Requirements

This site is best viewed with an HTML5 compatible browser, this list includes the current versions of Microsoft Internet Explorer, Mozilla Firefox, Google Chrome, and Apple's Safari. You can visit the independent (3rd party) site www.whatismybrowser.com to determine if you have the latest version of your browser. Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. That software may be: Adobe Flash, Apple Quicktime, Adobe Acrobat, Microsoft Powerpoint, Windows Media Player, and Real Networks Real One Player. Where such software is required it will be indicated.

Disclaimer

Med Learning Group makes every effort to develop CME activities that are scientifically based.This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

Participation Statement

This educational activity provides training necessary for licensed attendees to maintain state licensing requirements. The tuition for this educational activity is subsidized in part by unrestricted educational grants, including for those attendees who have successfully completed the state licensing requirements for their respective fields. This subsidy is reflected in the registration fees for this activity.

Content - Copyright © 2019 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.